A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination
- DOI
- 10.1080/14737140.2026.2677940
- Published
- 2026-05-27
- Container
- Expert Review of Anticancer Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14737140.2026.2677940,
title = {A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination},
author = {María José Soler and Laura Cosmai and Lui Forni and Jolanta Małyszko and Rukshana Shroff and Ben Sprangers and Corinne Isnard Bagnis},
year = {2026},
journal = {Expert Review of Anticancer Therapy},
doi = {10.1080/14737140.2026.2677940},
url = {https://doi.org/10.1080/14737140.2026.2677940}
}RIS
TY - JOUR TI - A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination AU - María José Soler AU - Laura Cosmai AU - Lui Forni AU - Jolanta Małyszko AU - Rukshana Shroff AU - Ben Sprangers AU - Corinne Isnard Bagnis PY - 2026 JO - Expert Review of Anticancer Therapy DO - 10.1080/14737140.2026.2677940 UR - https://doi.org/10.1080/14737140.2026.2677940 ER -
APA
Soler, M. J., Cosmai, L., Forni, L., Małyszko, J., Shroff, R., Sprangers, B., & Bagnis, C. I. (2026). A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2026.2677940
Source records
- crossref · retrieved 2026-09-26T14:30:29.255Z